James S. Killinger, M.D.

Dr. Corrina Oxford-Horrey is one of the few Obstetric Intensivists in the United States. She completed her medical school training at Howard University College of Medicine followed by an Obstetrics and Gynecology residency at Pennsylvania Hospital. In 2010, she went on to become the 9th person in the country with fellowship training and board certification in Maternal-Fetal Medicine and Critical Care Anesthesia. Both of her fellowships were completed at the Brigham & Women’s Hospital where she stayed on faculty with a dual appointment in the Division of Maternal-Fetal Medicine and Department of Surgery. While at Brigham & Women’s Hospital, she cared for critically ill mothers and served as attending faculty in the Surgical ICU, Thoracic Intermediate Care and Burn-Trauma Units. In 2012, she joined the University of Pennsylvania Health System where she spent 3 years as the Director of Obstetric Services at Pennsylvania Hospital maintaining her clinical focus on high acuity maternal care and administrative efforts in Quality Improvement and Patient Safety. She subsequently led the Critical Care Obstetrics and In-situ Simulation curriculum at the Hospital of the University of Pennsylvania where she was also the Co-Director of the Pregnancy and Heart Disease Program. Outside of her clinical duties in Maternal-Fetal Medicine, she served on the Philadelphia Maternal Mortality Review Board.Her publications include journal articles and chapters on hemodynamics of pregnancy, care of the pregnant surgical patient, and trauma in pregnancy. She has been the recipient of many teaching awards in her career and believes in “paying it forward” with mentorship of upcoming clinicians with particular enthusiasm for the care of high-risk obstetric patients.Dr. Oxford-Horrey brings her expertise to Weill Cornell Medical Center as the Director of Labor and Delivery, where she will continue to use simulation and collaborative care models to ensure the safest and highest quality inpatient experience for our patients.

Dr. Amy Chadburn is an outstanding diagnostic hematopathologist who is well liked by the local hematopathologists/oncologists for her daily contributions to patient care. She is widely respected within the hematopathology community nationwide. Her peers have voted her to be included in the Castle-Connolly Best Doctors in the New York metropolitan area for the last three years. The United States and Canadian Academy of Pathology has asked her to serve on their abstract review board and to moderate numerous scientific sessions. She has been invited to lecture throughout the United States and Europe on the areas of her special expertise, namely immunodeficiency-associated lymphoproliferative disorders. In addition to her clinical diagnostic expertise, and in spite of her large clinical service demands, Dr. Amy Chadburn has relentlessly pursued the scientific investigation of lymphoproliferative disorders throughout her career. She has collaborated with a large number of investigative activities which has resulted in more than 50 original publications. She has published numerous other original articles in her own right or with other collaborators. She received the coveted Arthur Purdy Stout Award in 1992 for the best paper published in the pathology literature by a pathologist under the age of 40. Her scholarly contributions cover virtually the entire range of lymphoproliferative disease. She is however best recognized nationally for her contributions to our understanding of AIDS-associated lymphoid neoplasia, post-transplantation lymphoproliferative disorders and the applications of flow cytometric and immunohistochemical technologies to the diagnosis, classification, and investigation of lymphoid neoplasia.

As an attending thoracic surgeon at Weill Cornell Medical Center, Dr Port has developed an interest in minimally invasive approaches to the diagnosis, staging and treatment of thoracic malignancies. He has have recently integrated Endobronchial Ultrasound (EBUS) and Electromagnetic Navigational Bronchoscopy (ENB) into the thoracic surgical program. These techniques offer a minimally invasive approach to lung cancer diagnosis and staging. Dr. Port specializes in lung and esophageal cancers, mediastinal tumors and Barrett's Esophagus. He also specializes in the area of minimally invasive thoracoscopic pulmonary surgery. Dr. Port has taken a leadership role on the development of the robotic surgical program and now offers robotic surgical approaches for mediastinal, lung and esophageal disorders.Dr. Port has authored numerous journal articles and book chapters on the treatment of lung and esophageal cancer. He has been selected as a best doctor in New York Magazine for 2012.Dr. Port resides with his family here in Manhattan.